Lotus Pharmaceutical Co Ltd (1795) — Long-term Investment Intensity
Lotus Pharmaceutical Co Ltd (1795) has a Long-term Investment Intensity of 2.6% as of December 2019. Long-term investments of NT$458.06 Million represent 2.6% of total assets of NT$17.92 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Lotus Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lotus Pharmaceutical Co Ltd Long-term Investment Intensity (2016–2019)
This chart shows how Lotus Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 2.6%, reflecting long-term investments of NT$458.06 Million against total assets of NT$17.92 Billion TWD. Also explore 1795 total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Lotus Pharmaceutical Co Ltd (2016–2019)
The table below presents the year-by-year Long-term Investment Intensity for Lotus Pharmaceutical Co Ltd from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Lotus Pharmaceutical Co Ltd (1795) market capitalisation.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.6% | NT$458.06 Million | NT$17.92 Billion | ▲ +2.5 pp |
| 2018 | 0.1% | NT$9.04 Million | NT$14.85 Billion | ▼ 0.0 pp |
| 2017 | 0.1% | NT$10.52 Million | NT$15.66 Billion | ▼ -0.1 pp |
| 2016 | 0.1% | NT$20.11 Million | NT$15.24 Billion | — |